
    
      Besides the main objective, there are 4 other objectives as follows:

        -  To assess the safety of Oratecan in combination with capecitabine

        -  To evaluate anticancer activity of Oratecan in combination with capecitabine in patients
           with advanced solid malignancies

        -  To characterize the pharmacokinetics of Oratecan and its metabolites following oral
           administration of OratecanTM in combination with capecitabine
    
  